McKesson (MCK) Statistics

McKesson Corp (MCK) is a renowned healthcare company that operates in the United States and globally. With a market cap of over $28 billion, McKesson holds a prominent position in the healthcare industry. Let's dive into some key statistics that shed light on its performance and position. McKesson Corp has a forward P/E ratio of 11.42, reflecting an expectation of future earnings growth. The company's price-to-sales ratio stands at 0.13, indicating a favorable valuation compared to its revenue. Additionally, McKesson's price-to-book ratio of 2.24 suggests a reasonable valuation based on its assets. When it comes to profitability, McKesson boasts a profit margin of 1.93%, demonstrating its ability to generate earnings from its operations.

Comparing McKesson's stock performance with its sector, we can see that it has outperformed the industry average. Over the past year, McKesson's stock has shown a return of 27.55%, while the sector's average return stands at 16.73%. This indicates that McKesson has delivered strong performance and has been able to capitalize on market opportunities to create value for its shareholders. In terms of revenue per share, McKesson has achieved $224.40, highlighting its ability to generate substantial revenue from its operations. Moving on to the company's financial health, McKesson's enterprise to EBITDA ratio stands at 9.63, indicating its ability to generate significant earnings before interest, taxes, depreciation, and amortization. Finally, McKesson's total debt amounts to $30.73 billion, reflecting its financial leverage in the market. However, the company's gross profit of $50.35 billion showcases its strong revenue generation capabilities.